Newsbenzinga
Biohaven Discloses That FDA Demanded Pause In BHV7000-303 Enrolment; Dosing Continues And Topline Data Readout Remains On Timeline For H2 2026
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…